Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

White House reporters were abruptly rushed out of the Oval Office after a press conference attendee suffered a medical ...

Get the latest news and live updates as the government shutdown enters Day 37, with FAA cuts to flights and energy bill assistance cuts looming.

CMS introduced the GENEROUS Model to reduce Medicaid drug costs, enhance access, and improve health outcomes for ...

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist ...

The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower the cost of GLP-1 drugs for many Americans.

WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand ...

The White House announced reduced pricing for the popular weight-loss drugs made by Eli Lilly and Novo Nordisk.

It appears that President Donald Trump’s angry social media posts have once again landed him in hot water in the courts: A ...

Eli Lilly and Novo Nordisk will lower prices for GLP-1 drugs, aligning with new drug pricing initiatives and Medicare Part D pilot coverage starting April 2026. Lilly's Zepbound and orforglipron will ...